[Treatment of essential hyperlipidemia with procetofene. Apropos of 100 cases].
作者信息
Fromantin M, Gautier D, Bon R
出版信息
Sem Hop Ther. 1977 May-Jun;53(5-6):311-6.
PMID:897691
Abstract
摘要
相似文献
1
[Treatment of essential hyperlipidemia with procetofene. Apropos of 100 cases].[用普罗赛芬治疗原发性高脂血症。附100例报告]
Sem Hop Ther. 1977 May-Jun;53(5-6):311-6.
2
Effects of CH 13.437 in different types of hyperlipidemia.
Arch Int Pharmacodyn Ther. 1972 Apr;196:Suppl 196:298+.
3
Lipid-lowering effects of procetofene.普罗西芬的降脂作用。
Lancet. 1977 Aug 6;2(8032):311. doi: 10.1016/s0140-6736(77)91009-1.
4
Focus on fenofibrate.关注非诺贝特。
Hosp Pract (Off Ed). 1988 Jun;23 Suppl 1:31-40. doi: 10.1080/21548331.1988.11703636.
5
Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.
Indian J Med Res. 1971 Oct;59(10):1621-32.
6
7
8
Treatment of primary hyperlipoproteinaemias with a tetralin derivative (Su-13'437).用一种四氢化萘衍生物（Su-13'437）治疗原发性高脂蛋白血症。
Atherosclerosis. 1973 May-Jun;17(3):383-8. doi: 10.1016/0021-9150(73)90029-4.
9
[Effectiveness of new lipotropic preparations in hyperlipemia].[新型促脂药物在高脂血症中的疗效]
Kardiologiia. 1971 Aug;11(8):26-30.
10
[The antidyslipoproteinemic activity of ufibrate in patients with non-insulin-dependent diabetes mellitus].
Lik Sprava. 1997 Sep-Oct(5):150-2.
Zotero 插件